Sort   by:  
 Page size 
UnknownPertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Not available
S-EPMC6781620 | biostudies-literature
UnknownTargeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Not available
S-EPMC9743163 | biostudies-literature
UnknownAtezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study.
Not available
S-EPMC9394388 | biostudies-literature
UnknownMyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors.
Not available
S-EPMC10824375 | biostudies-literature
UnknownctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.
Not available
S-EPMC7618057 | biostudies-literature
UnknownCNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Not available
S-EPMC10182308 | biostudies-literature
UnknownEfficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244 | biostudies-literature
UnknownA second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689 | biostudies-literature
UnknownMapping the human genetic architecture of COVID-19.
Not available
S-EPMC8674144 | biostudies-literature
UnknownValue of risk scores in the decision to palliate patients with ruptured abdominal aortic aneurysm.
Not available
S-EPMC6055637 | biostudies-literature
Sort   by:  
 Page size